Temasek Holdings (Private) LTD Ac Immune Sa Transaction History

Temasek Holdings (Private) LTD

  • $24.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$6.04 - $8.37 $15.8 Million - $21.9 Million
-2,614,095 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$7.88 - $16.45 $10.1 Million - $21 Million
1,276,595 Added 95.45%
2,614,095 $20.9 Million
Q3 2017

Nov 14, 2017
BUY
$7.06 - $11.2 $9.44 Million - $15 Million
1,337,500
1,337,500 $14.9 Million

Others Institutions Holding ACIU

# of Institutions
48
Shares Held
28.2M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $224M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email